3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine

3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin‑8‑amine is a synthetic small molecule belonging to the imidazopyridine class of organic compounds. It features a polycyclic aromatic structure with bromine and phenyl substituents and a pyrimidinylmethyl side chain. The compound has been identified as an experimental molecule and is not approved for clinical use in any jurisdiction. Structural studies indicate it acts as an ATP-binding inhibitor of cyclin-dependent kinase 2 (CDK2), suggesting potential utility in modulating cell cycle progression or cancer biology; however, there are no reported clinical trials or approved indications for this agent[1][4][10].

Other names

N-(5-pyrimidinylmethyl)-3-bromo-6-phenylimidazo[1,2-a]pyridine-8-amine